Biolife Solutions (BLFS) Net Cash Flow (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Net Cash Flow data on file, last reported at -$10.2 million in Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$10.2 million, up 64.08% year-over-year; the trailing twelve-month figure through Mar 2026 was -$44.1 million (down 218.75% YoY), and the FY2025 annual result was -$62.3 million, down 204.0% from the prior year.
• Net Cash Flow slipped to -$10.2 million in Q1 2026 per BLFS's latest filing, from $3.6 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $71.2 million in Q4 2024 and troughed at -$35.3 million in Q2 2022.
• A 5-year average of -$2.8 million and a median of -$2.4 million in 2025 frame the typical range for Net Cash Flow.
• The sharpest annual moves came in 2022 and 2024: Net Cash Flow soared 407.94% in 2022, then sank 1522.99% in 2024.
• A 5-year view of Net Cash Flow shows it stood at -$7.7 million in 2022, then soared by 310.25% to $16.1 million in 2023, then soared by 341.96% to $71.2 million in 2024, then tumbled by 95.0% to $3.6 million in 2025, then slumped by 387.21% to -$10.2 million in 2026.
• Business Quant data shows BLFS's Net Cash Flow at -$10.2 million in Q1 2026, $3.6 million in Q4 2025, and -$2.4 million in Q3 2025.